HEERAIN SHAH: Open Payments
NPI 1134346828 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,892 in 152 payments from 18 companies in 2025. Trend: 2023 $2,584 · 2024 $2,119 · 2025 $2,892
Food & beverage: $2,892
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 20 | $519 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $463 |
| Axsome Therapeutics, Inc. | 9 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $221 |
| Vanda Pharmaceuticals Inc. | 11 | $195 |
| Corium, LLC | 13 | $190 |
| Alkermes, Inc. | 10 | $182 |
| ABBVIE INC. | 13 | $176 |
| Collegium Pharmaceutical, Inc. | 10 | $163 |
| Noven Therapeutics, LLC | 6 | $133 |
Products named: CAPLYTA, INVEGA SUSTENNA, REXULTI, Auvelity, Azstarys, VRAYLAR, Jornay PM, LYBALVI.
Industry payments across GA — which companies pay providers there.
